Immunoregulatory effects of CD4+ T helper subsets in human melanoma
- 30 April 1995
- Vol. 117 (4) , 365-372
- https://doi.org/10.1016/s0039-6060(05)80054-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivoEuropean Journal of Immunology, 1993
- CD4+ T Cell Clones Isolated from Human Renal Cell Carcinoma Possess the Functional Characteristics of Th2 Helper CellsCellular Immunology, 1993
- Human melanoma cells express a functional interleukin‐2 receptorInternational Journal of Cancer, 1993
- Interleukin‐10 production by human carcinoma cell lines and its relationship to interleukin‐6 expressionInternational Journal of Cancer, 1993
- A TH1→TH2 switch is a critical step in the etiology of HIV infectionImmunology Today, 1993
- The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.The Journal of Experimental Medicine, 1992
- Human tumor-infiltrating lymphocyte (TIL) cytotoxicity facilitated by anti-T-cell receptor antibodyInternational Journal of Cancer, 1989
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977